Evidence map›Paper›PMID 33919113›Full record

ReviewInternational journal of molecular sciences2021

Hypophosphatasia: A Unique Disorder of Bone Mineralization.

Juan Miguel Villa-Suárez, Cristina García-Fontana, Francisco Andújar-Vera, Sheila González-Salvatierra, Tomás de Haro-Muñoz, Victoria Contreras-Bolívar, Beatriz García-Fontana, Manuel Muñoz-Torres

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. A randomized Phase 1b trial evaluating the pharmacodynamics of ilofotase alfa in adults with hypophosphatasia.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Trial
  2. Article
  3. Article
  4. Article
  5. Functional andCells · 2025
    Article
  6. Review
  7. Review
  8. Disease burden byJournal of medical genetics · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Juan Miguel Villa-SuárezClinical Analysis Unit, University Hospital Clínico San Cecilio, 18016 Granada, Spain.
Cristina García-FontanaInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0002-9328-6022
Francisco Andújar-VeraInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Sheila González-SalvatierraInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Tomás de Haro-MuñozClinical Analysis Unit, University Hospital Clínico San Cecilio, 18016 Granada, Spain.
Victoria Contreras-BolívarInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.
Beatriz García-FontanaInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0002-4134-5561
Manuel Muñoz-TorresInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain.ORCID 0000-0002-9645-3260
Instituto de Investigación Biosanitaria de Granada · ESInstituto de Salud Carlos III · ESUniversidad de Granada · ES

Funding

Institute of Health Carlos III CD20/00022Institute of Health Carlos III CM19/00188Institute of Health Carlos III PI18-00803Institute of Health Carlos III PI18-01235
6 · The paper itself

Abstract

Hypophosphatasia (HPP) is a rare genetic disease characterized by a decrease in the activity of tissue non-specific alkaline phosphatase (TNSALP). TNSALP is encoded by the

Indexed as

MutationAlkaline PhosphataseCalcinosisEnzyme Replacement TherapyHumansHypophosphatasiaAlkaline PhosphataseALPL protein, humanasfotase alfagenotype-phenotypehypophosphatasiapyridoxal-5′-phosphateTNSALP

Identifiers

PMID33919113
PMCPMC8122659
OpenAlexW3153787093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.